imiquimod has been researched along with shikonin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Gao, XH; Geng, L; Lan, XO; Liu, XY; Xu, YY; Yu, YJ; Zhang, XL | 1 |
| Gao, XH; Geng, L; Guo, H; Lan, XO; Qi, RQ; Wang, HX; Xu, YY; Yang, Y; Yu, YJ | 1 |
| Cha, X; Chen, Y; Lai, B; Tao, T; Wang, J; Wang, W; Xiao, W | 1 |
4 other study(ies) available for imiquimod and shikonin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Shikonin induces apoptosis and suppresses growth in keratinocytes via CEBP-δ upregulation.
Topics: Animals; Apoptosis; CCAAT-Enhancer-Binding Protein-delta; Cell Line; Cell Proliferation; Humans; Imiquimod; Janus Kinases; Keratinocytes; Male; Mice, Inbred BALB C; Naphthoquinones; Psoriasis; STAT3 Transcription Factor; Up-Regulation | 2019 |
Shikonin inhibits CEBPD downregulation in IL‑17‑treated HaCaT cells and in an imiquimod‑induced psoriasis model.
Topics: Animals; CCAAT-Enhancer-Binding Protein-delta; Cell Proliferation; Disease Models, Animal; Down-Regulation; HaCaT Cells; Humans; Imiquimod; Interleukin-17; Interleukin-6; Mice; Naphthoquinones; Psoriasis; Signal Transduction; STAT3 Transcription Factor | 2020 |
Shikonin combined with methotrexate regulate macrophage polarization to treat psoriasis.
Topics: Animals; Imiquimod; Lipopolysaccharides; Macrophages; Methotrexate; Mice; Naphthoquinones; Psoriasis | 2022 |